Loading cancer entity…
Loading cancer entity…
Clinical trials
163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (28)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02314156 | Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy | completed | Phase 2 | 67 | Northwestern UniversityOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT04248179 | The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. | completed | Phase 4 | 36 | Zealand University HospitalOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT03775213 |
| Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS) |
| completed |
| N/A |
| 322 |
| Duke UniversityOTHER |
| 1 |
| Jan 30, 2023 |
| clinicaltrials |
| NCT03323658 | Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2023 | clinicaltrials |
| NCT04170920 | Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs | completed | N/A | 62 | Indiana UniversityOTHER | 1 | Sep 14, 2022 | clinicaltrials |
| NCT04985032 | Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) | recruiting | — | 200 | RPCR, Inc.OTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT04349111 | An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite" | withdrawn | N/A | 0 | Xoft, Inc.INDUSTRY | 0 | Aug 2, 2022 | clinicaltrials |
| NCT04666961 | Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ(HORNEO01) | recruiting | Phase 2 | 262 | Institut Cancerologie de l'OuestOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT04866992 | Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)(SPrNSM) | completed | — | 10 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT01849250 | Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Dec 28, 2021 | clinicaltrials |
| NCT02137252 | Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer | terminated | Phase 2 | 3 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT03834532 | Living Well After Breast Surgery | completed | N/A | 17 | University of Texas at AustinOTHER | 1 | Nov 2, 2021 | clinicaltrials |
| NCT02909426 | The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness(MUST-BE) | unknown | — | 11,880 | Soonchunhyang University HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT03931928 | Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients(TAMENDOX) | completed | Phase 2 | 356 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)OTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT01448447 | Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®(Mammosite ML) | completed | N/A | 20 | Mercy ResearchOTHER | 1 | Jul 15, 2021 | clinicaltrials |
| NCT01023477 | Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) | completed | Phase 1 / Phase 2 | 12 | Inova Health Care ServicesOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT00256217 | Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women | completed | Phase 2 | 42 | Rita Sanghvi, MehtaOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT03437915 | BrUOG 351: PRE-OPERATIVE APBI USING NIBB(351) | withdrawn | N/A | 0 | Jaroslaw HepelOTHER | 0 | Mar 9, 2021 | clinicaltrials |
| NCT00496808 | Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | completed | N/A | 69 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT02061332 | DC Vaccine for Patients With Ductal Carcinoma In Situ(DCIS6) | completed | Phase 1 / Phase 2 | 58 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 10, 2020 | clinicaltrials |
| NCT01060345 | A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ | terminated | Phase 2 | 20 | University of ChicagoOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT03109522 | Axillary Reverse Mapping (ARM) Technique(ARM) | unknown | N/A | 130 | McMaster UniversityOTHER | 1 | Feb 21, 2020 | clinicaltrials |
| NCT02766881 | Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS(DUCHESS) | completed | — | 281 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT02961790 | Oxybutynin Chloride in Managing Hot Flashes | completed | Phase 3 | 150 | Academic and Community Cancer Research UnitedOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT01753908 | Broccoli Sprout Extract in Treating Patients With Breast Cancer | completed | Early Phase 1 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Oct 31, 2019 | clinicaltrials |
| NCT01869764 | Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | completed | Phase 2 | 57 | Wake Forest University Health SciencesOTHER | 1 | Oct 30, 2019 | clinicaltrials |
| NCT01815476 | The Prone Breast Radiation Therapy Trial | completed | N/A | 378 | Toronto Sunnybrook Regional Cancer CentreOTHER | 1 | Sep 11, 2019 | clinicaltrials |
| NCT02248662 | Impact of Radiation Therapy on Breast Conservation in DCIS | completed | — | 3,436 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT01975363 | Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer | completed | N/A | 29 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT04046159 | Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ | unknown | Phase 3 | 810 | National Taiwan University HospitalOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT02216136 | Tumor: Breast Ratio Study(T:B) | completed | — | 162 | Washington University School of MedicineOTHER | 1 | Aug 2, 2019 | clinicaltrials |
| NCT01138553 | Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer | terminated | Early Phase 1 | 4 | University of California, San DiegoOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT02370277 | Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer | completed | — | 36 | University of Southern CaliforniaOTHER | 1 | Jun 18, 2019 | clinicaltrials |
| NCT02587663 | Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI | completed | N/A | 300 | University of Southern CaliforniaOTHER | 1 | May 16, 2019 | clinicaltrials |
| NCT02908178 | Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ | completed | — | 28,291 | Yale UniversityOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT02817607 | Study to Assess Breast Sensation Before and After Breast Cancer Treatment | withdrawn | N/A | 0 | Duke UniversityOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT00886535 | Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity | completed | — | 41 | Milton S. Hershey Medical CenterOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT03430765 | Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy | completed | N/A | 62 | Katherine HadlandsmythOTHER | 1 | Feb 11, 2019 | clinicaltrials |
| NCT01194440 | Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms | completed | Phase 2 | 63 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT02224807 | Effects of Diet and Exercise on Ductal Carcinoma in Situ(DCIS) | completed | N/A | 32 | University of Alabama at BirminghamOTHER | 1 | Aug 31, 2018 | clinicaltrials |
| NCT02150525 | Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors | completed | Phase 2 | 52 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT02168179 | KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT02023008 | Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy | terminated | N/A | 6 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT00555152 | Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ | completed | N/A | 22 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2018 | clinicaltrials |
| NCT02365714 | CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)(CK-SAPBI) | terminated | Phase 1 / Phase 2 | 2 | Georgetown UniversityOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT01723943 | Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients | completed | N/A | 108 | University of WashingtonOTHER | 1 | Feb 8, 2018 | clinicaltrials |
| NCT01372618 | Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor | terminated | Phase 1 / Phase 2 | 9 | NYU Langone HealthOTHER | 1 | Dec 27, 2017 | clinicaltrials |
| NCT01754519 | Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery | terminated | Phase 2 | 1 | Roswell Park Cancer InstituteOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT01729832 | Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer | withdrawn | N/A | 0 | Ohio State University Comprehensive Cancer CenterOTHER | 0 | Apr 13, 2017 | clinicaltrials |
| NCT01060085 | Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging | completed | — | 51 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 23, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Feb 22, 2023source: clinicaltrials